U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07670624) titled 'T6A Biomarker for Detection of Bacterial Infection in Newborn Infants' on June 02.
Brief Summary: This study aims to assess the efficacy of a new biomarker, N6-threonylcarbamoyladenosine (t6A), for the early diagnosis of Early-Onset Sepsis (EOS) in newborns.
Study Start Date: July 01
Study Type: OBSERVATIONAL
Condition:
Sepsis
Newborn Sepsis
Biomarker Discovery
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Salzburger Landeskliniken
Information provided by (Responsible Party): Lorenz Auer-Hackenberg, Salzburger Landeskliniken
Published by HT Digital Content Services with permission from Health Daily Digest....